Quick Takeaways
- Zoetis has entered into a definitive agreement to acquire the animal genomics business of Neogen Corporation for $160 million, strengthening its push into Precision Animal Health and livestock innovation.
- Neogen’s genomics unit operates across 120+ countries, backed by labs in the US, Brazil, Australia, China, and the UK, offering advanced genotyping, sequencing, and data-driven insights, with strong leadership in US beef and dairy genomics.
- Once closed (expected in H2 2026, subject to approvals), the deal will enhance Zoetis’ ability to deliver predictive insights, individualized animal care, and improved productivity, supporting more sustainable livestock production globally.
Why It Matters?
Zoetis vaults into genomics leadership, fusing Neogen’s lab network with its biologics portfolio to dominate precision breeding and herd management.
Deal crushes smaller agtech players, handing ranchers data-driven productivity tools that slash disease losses while meeting sustainability mandates.
Global livestock producers gain integrated genomics + health platforms, cementing Zoetis dominance across beef, dairy, and swine production chains.
Source: Businesswire
